Google TrendSELMA BLAIR (2000+) — Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Pooled Safety Analysis Su" (18 stories)

Top Headline Story

Sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis of its clinical benefit and safety
Lead StoryFrontiersgeneral
Sep 7

Sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis of its clinical benefit and safety

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQcXR5dlZhbWswdTZidEJoVlpxSVU0UTdqbDZQdVA2WTNDSXFYYndpM2l6Y2RhcHl0TklteHNubkRkZXNQdUVvb3RXR0RPdXVBYzVVZldpUl96aHRYaldRR0xxX1dmc2FMUkhiVUttZFJRVUs5X1Y5clhZV1gtaEowY1RVdUNXYW5NYU9nNEl3?oc=5" target="_blank">Sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis of its clinical benefit and safety</a>  <font color="#6f6f6f">Frontiers</font>

Real-time search volume
2000+29m ago

selma blair

Selma Blair Arrested, Attacks Flight Crew After Trying to Open Plane Door Mid-Air

2000+39m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

500+39m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

200+39m ago

peggy flanagan

Minnesota Poll: Flanagan holds narrow lead over Tafoya in U.S. Senate race

Search Results for "Pooled Safety Analysis Su"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

17 stories displayed
Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Cureusgeneral

Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxNUmY1dDZsNFNqMHNrQ3lSTFhDWm5rWWNmLUhlbnZlOW1kVFBkTTdsaWR4amhZU3hoZi1fSWtvMzQyaHJ5SGg0UHlVX0ZIYWFVU2pGbVpKREQwdkR5eEtmcGx4SzNPcW5KanBhRlNzY1FfUE0xMUxSSVMyRVhPdGdqM3dlZXAyX29WQ3RWN1duekd2dm5mSmZVUnp5LUlSQ1djd2l5LVpONHZFWUQwa0dMRkhyWlctQzVpelc0ZjNfSHRYUG1qcWp2RW82X0V5VUxyck81ZEpTYmFNUEhOcy1XZ2VWVFIzMm9jSDNid1JzOTJ0RDNrZm5kSHRpbEs?oc=5" target="_blank">Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</a>  <font color="#6f6f6f">Cureus</font>

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials
Natureworld

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE56TVJSWDMteFN6OUloRkxaeFdXSFRycW5ZSWhibXB1Vi1JM1JRWkJwSmxaRDQyUW1aYjNqMUV2RTY4QmZHUEV6U29hcDJBUndqaDdKSHZ6R0VlTHhjanVv?oc=5" target="_blank">Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials</a>  <font color="#6f6f6f">Nature</font>

Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms
Patient Care Onlinegeneral

Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNajR5NUhmSWROVnU3dXRzZk8xTnYtbGhVS2dlYmVhbmVFa1N0NnZlVGNlZi1ocjBEbTRkTERBTTNQbGN5Z2F5N21WTGtXYXVlUWxiMHl4Tm1HalFqOUMxd1A5djc4WGxZSVFGM3dyczBSdUU5RlpNVXNFWHhlWmoteElScnBDT08yblZzUVh3bWU3UjRidHNnSUtkOUVmYW9IbTloWVVhWUt1bU5sMldjeDJmYzhVOWpMclduRlo4RGc2dDViUG5wdTRUSFpyeTdpTE9xRDk2Uy1jRXNhcXBmblFOTUR4UFFwa0pIOQ?oc=5" target="_blank">Four Studies Build Evidence for Elinzanetant as a Safe, Effective Nonhormonal Option for Menopausal Vasomotor Symptoms</a>  <font color="#6f6f6f">Patient Care Online</font>

A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
The New England Journal of Medicinegeneral

A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE84SjdTT1pQV3lfS1FFU3lnUHpWSVVUUldFWGFoaWlrWHFkRWExeGludXBOaG10UXpDenh4eWVrOE5kc3RCckJzOS1UM2xEd01kSUxOTFBETVh1Vm0yNFBZ?oc=5" target="_blank">A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials
medRxivgeneral

COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE45SV9EU0E5RWN6TjZNaGl2QUw5dVhUSXNtV3J3ZEpKMXpoSTQ4MW1VYUxTU3h3eWY2UE1MVFNVdzh3NGpIT1Jza3dWOVE5OGNqTDZoU3V2TjdSakpLMEFPeE02TzRFRVZpeTBSUEFKUEJvQQ?oc=5" target="_blank">COVID-19 Vaccine Safety Studies among Vulnerable Populations: A Systematic Review and Meta-analysis of 120 Observational Studies and Randomized Clinical Trials</a>  <font color="#6f6f6f">medRxiv</font>

Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervo
Wiley & Sonsgeneral

Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervo

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTFBXc01NblRqN2pKcTVlMldIN0lHNGpGdDZQS0VFdi10LXpnZGRwaEVuSHZzQjRmM080WUM4SWVyRGlkTzl5OW1faUZfaUM3YXc4QzhMQnFlRWNzcF95a3ozYnRDY3IydkIxYzR3QU8wS20xS0Y3LVZrQmJnQQ?oc=5" target="_blank">Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervo</a>  <font color="#6f6f6f">Wiley & Sons</font>

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
The Lancettech

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNOUVSZ0NkRDF3VmtpbE4tT3BUb2ZoX0Q1Sk5abDBYcm5PdVVuTl9CbWJKZ0trazdBSTdNNWNNdHoydVp0d291ZnMwa2J3N01QazU4UGNIMEl0cTJWV1dVWjNvanNMem93RmZGNVAzcXVySlVXOHFxRkVfaUdmQzhsOFFuT2dKVXN3UU00?oc=5" target="_blank">Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials</a>  <font color="#6f6f6f">The Lancet</font>

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
The New England Journal of Medicineworld

Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9RcVZ0RFpMQ1V3SGJlek5rVnp4aDlqdDB5My1QendEUmxuOFBuRDZybkY1RlJHRGFsdHNZQ3g4cXpUZGRaVmtLUm1RdUxwZDM0NnJsblRJT0Rlc3BlTHpZag?oc=5" target="_blank">Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis</a>  <font color="#6f6f6f">The New England Journal of Medicine</font>

Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis
Naturegeneral

Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFB1a2x3YnVTdmVjZGptbmxQbDZCdjlObFN2dXJUTWRwa1pJOHFPRWZNSFdQalJTVUNkLWs5eDhQdzZVOW5EOExRMWFiMjZzU0Qydk9QcVNOTmVveGtZZEMw?oc=5" target="_blank">Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis</a>  <font color="#6f6f6f">Nature</font>

Short-course therapy for diarrhea-predominant irritable bowel syndrome | CEG
Dove Medical Press Ltdgeneral

Short-course therapy for diarrhea-predominant irritable bowel syndrome | CEG

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNUENRd2Jwd01nRS1VREo5VC1ScUM4WVhlbnpreW5xRHVwODd1Yk1LT3V4OThvX3puZVhwZVVNSWhWTXRfeDFXRjZmLUYxT1IyU3Y1eHNrcVEzUkNHZ3VDd0h6MnlTVE9qQ3N1NGQyM2hEMXF2SlVZOGREMkw3eTV2eUZTUEJoczByelJBUm1IWklUVHcwU1JsaWZBLXpTY1pCZWJESlhaSmdCbEU0d2hSbmFVb3M5b25zOV96NmJWNnVyRWtNVWs0cmtKYw?oc=5" target="_blank">Short-course therapy for diarrhea-predominant irritable bowel syndrome | CEG</a>  <font color="#6f6f6f">Dove Medical Press Ltd</font>

Journal of the European Academy of Dermatology and Venereology
Wiley Online Libraryworld

Journal of the European Academy of Dermatology and Venereology

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE53LUt2U1I2aTNsN0R1V2t2Z194Z2E0OHdzWGpscTQ4cFVodllZT0hiZml2Qms1Uy1rT3BxSWpVbWNWWTF0SVRnWUVCNHVQSjlzdU1nelhMdVVoVVZUeGozTW1fZDZaQzFkbnc?oc=5" target="_blank">Journal of the European Academy of Dermatology and Venereology</a>  <font color="#6f6f6f">Wiley Online Library</font>

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
The Lancetgeneral

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQV25yM1g1NG1yQUM5OTZUeXFZYkNCRDNIRUluVHlrNVU2SnExaGpmQkljN2stTmMxSm9nRlJsY09FcE0tcDJlM192RFJOZWFidE9GejJuS1J0dWZUcHpldjZYelAwRjBKVUN4UnZBYkVYNEZwZHo4ZEFQaGFsRkN4X1luRWg2TzMwSm9v?oc=5" target="_blank">Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales</a>  <font color="#6f6f6f">The Lancet</font>

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
NEJMworld

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5RLXlNWlFWTUF0eHJ0dGJnR1J6NzYzMVNTTm5jM0wwQzZRR05XM0ZLcVY5VTNSanF3NjRpbGhhazNYMXl1dWRubmpBVlNsbGtNOXpoZ0gtdGZTNmtqUHVOUQ?oc=5" target="_blank">Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older</a>  <font color="#6f6f6f">NEJM</font>

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
The Lancetworld

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNSkhCbHFrOUZsS3FmLW0xT0VxekJCY19OTXVQVFNydE1DM0xGMjlESUdTZlBjTC03YWJFQXIxWTBDYU43R203VzkwekVncl9zOTg0dnVTS3VvUTU1Yld2a19IWnZNSkYxa0t0aGJ5Q0VvNlp0Y2l3Q3Zab2w1YTRCbWtRYVlhQy04ZlRV?oc=5" target="_blank">Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials</a>  <font color="#6f6f6f">The Lancet</font>

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
Naturegeneral

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5oR0Y3Y09sY2F4VlNHUndQb2pLd0JqeHZVRnEwd2NKd0hWek5WUENndWZlVWgtUkNqTWdPZXZsQ091dXZjM3NsVmdpcjcwOHI3UTZiM1I5MXlZQmw3ZFpz?oc=5" target="_blank">Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis</a>  <font color="#6f6f6f">Nature</font>

Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial
Natureworld

Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE81dmY1N3dwbWxaMmsydUpMdDRMY1BDY0ZTY3dmN2hCMWN5UTBlMjlxZEtzN0Y4dG13T01rVGwzQmFEMHlJWlhUVXZ5cmNVaHhzUXVPaDJReEpYalF2emhF?oc=5" target="_blank">Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial</a>  <font color="#6f6f6f">Nature</font>

Weight management using a meal replacement strategy: meta and pooling analysis from six studies
Naturegeneral

Weight management using a meal replacement strategy: meta and pooling analysis from six studies

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE8tSmFoUVVVOHFmQW1jRGpJWXpEZXZrNGV3cHJKRmFpdnM2TVFkdWM2emw0enpEZGVUQUowWENYZlFRQmFscjRScnNNRVl5RTIz?oc=5" target="_blank">Weight management using a meal replacement strategy: meta and pooling analysis from six studies</a>  <font color="#6f6f6f">Nature</font>

"Pooled Safety Analysis Su" — Live Google News Trends & Headlines